Oncocross

South Korea
Seoul, Seoul, South Korea

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
3
Total equity funding
$15.2M
Last funding
Corporate Round / $881,843 / 2021-03-04
Last equity funding
Corporate Round / $881,843
Investors
15
Lead investors
2
Founders
1
Articles
18
Exited on
2024-12-18

Founders and investors

Founders

Yi Rang Kim

Lead investors

Daewoong PharmaceuticalTIPS Program

Investors

Daewoong PharmaceuticalKB SecuritiesKDB CapitalSmilegate InvestmentTIPS Program